Breaking News

Over a week ago Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
Conference/Events	Inspire Medical participates in a webcast with Wells Fargo » 10:25 04/01/21 04/01 10:25 04/01/21 10:25 INSP Inspire Medical $216.00 / +9.27 (+4.48%) Wells Fargo hosts… Wells Fargo hosts management in its MedTech Research & Development R&D Spotlight webcast on April 1 at 11 am. Webcast Link ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events INSP Inspire Medical $216.00 / +9.27 (+4.48%) 03/31/21 Inspire Medical receives FDA approval for physician programmer platform 03/15/21 Inspire Medical gets FDA approval of two-incision implant procedure 01/19/21 Inspire appoints Bryan Phillips as chief compliance officer, general counsel 11/03/20 Inspire Medical rises 23.2% INSP Inspire Medical $216.00 / +9.27 (+4.48%) 02/24/21 Lake Street Inspire Medical price target raised to $250 from $215 at Lake Street 02/24/21 SVB Leerink Inspire Medical price target raised to $275 from $225 at SVB Leerink 02/24/21 Piper Sandler Inspire Medical price target raised to $252 from $210 at Piper Sandler 01/07/21 Lake Street Inspire Medical price target raised to $215 from $150 at Lake Street INSP Inspire Medical $216.00 / +9.27 (+4.48%) 11/02/20 Inspire Medical raises FY20 revenue view to $110M-$112M from $88M-$92M 11/02/20 Inspire Medical reports Q3 EPS (39c), consensus (72c) 14 Apr INSP Inspire Medical $216.00 / +9.27 (+4.48%) 03/15/21 Fly Intel: After-Hours Movers 11/03/20 Fly Intel: Wall Street's top stories for Tuesday 11/03/20 Fly Intel: Wall Street's top stories at midday 11/02/20 Fly Intel: After-Hours Movers 04/01/21 Inspire Medical - INSP 04/29/21 Inspire Medical Systems, Inc.
Conference/Events	Inspire Medical participates in a webcast with Wells Fargo » 08:28 04/01/21 04/01 08:28 04/01/21 08:28 INSP Inspire Medical $206.73 / +9.74 (+4.94%) Wells Fargo hosts… Wells Fargo hosts management in its MedTech Research & Development R&D Spotlight webcast on April 1 at 11 am. Webcast Link ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events INSP Inspire Medical $206.73 / +9.74 (+4.94%) 03/31/21 Inspire Medical receives FDA approval for physician programmer platform 03/15/21 Inspire Medical gets FDA approval of two-incision implant procedure 01/19/21 Inspire appoints Bryan Phillips as chief compliance officer, general counsel 11/03/20 Inspire Medical rises 23.2% INSP Inspire Medical $206.73 / +9.74 (+4.94%) 02/24/21 Lake Street Inspire Medical price target raised to $250 from $215 at Lake Street 02/24/21 SVB Leerink Inspire Medical price target raised to $275 from $225 at SVB Leerink 02/24/21 Piper Sandler Inspire Medical price target raised to $252 from $210 at Piper Sandler 01/07/21 Lake Street Inspire Medical price target raised to $215 from $150 at Lake Street INSP Inspire Medical $206.73 / +9.74 (+4.94%) 11/02/20 Inspire Medical raises FY20 revenue view to $110M-$112M from $88M-$92M 11/02/20 Inspire Medical reports Q3 EPS (39c), consensus (72c) 14 Apr INSP Inspire Medical $206.73 / +9.74 (+4.94%) 03/15/21 Fly Intel: After-Hours Movers 11/03/20 Fly Intel: Wall Street's top stories for Tuesday 11/03/20 Fly Intel: Wall Street's top stories at midday 11/02/20 Fly Intel: After-Hours Movers 04/01/21 Inspire Medical - INSP 04/29/21 Inspire Medical Systems, Inc.
Hot Stocks	Inspire Medical receives FDA approval for physician programmer platform » 16:22 03/31/21 03/31 16:22 03/31/21 16:22 INSP Inspire Medical $206.73 / +9.74 (+4.94%) Inspire Medical announced… Inspire Medical announced receipt of FDA approval for the new Inspire physician programmer platform. The company said the most significant enhancement associated with this approval is the new telemetry cable which enables Bluetooth connectivity to the programmer tablet. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events INSP Inspire Medical $206.73 / +9.74 (+4.94%) 03/15/21 Inspire Medical gets FDA approval of two-incision implant procedure 01/19/21 Inspire appoints Bryan Phillips as chief compliance officer, general counsel 11/03/20 Inspire Medical rises 23.2% 11/03/20 Inspire Medical rises 19.1% INSP Inspire Medical $206.73 / +9.74 (+4.94%) 02/24/21 Lake Street Inspire Medical price target raised to $250 from $215 at Lake Street 02/24/21 SVB Leerink Inspire Medical price target raised to $275 from $225 at SVB Leerink 02/24/21 Piper Sandler Inspire Medical price target raised to $252 from $210 at Piper Sandler 01/07/21 Lake Street Inspire Medical price target raised to $215 from $150 at Lake Street INSP Inspire Medical $206.73 / +9.74 (+4.94%) 11/02/20 Inspire Medical raises FY20 revenue view to $110M-$112M from $88M-$92M 11/02/20 Inspire Medical reports Q3 EPS (39c), consensus (72c) 14 Apr INSP Inspire Medical $206.73 / +9.74 (+4.94%) 03/15/21 Fly Intel: After-Hours Movers 11/03/20 Fly Intel: Wall Street's top stories for Tuesday 11/03/20 Fly Intel: Wall Street's top stories at midday 11/02/20 Fly Intel: After-Hours Movers 04/29/21 Inspire Medical Systems, Inc.

Over a month ago
On The Fly	Fly Intel: After-Hours Movers » 19:07 03/15/21 03/15 19:07 03/15/21 19:07 ZDGE Zedge $11.48 / +1.2 (+11.67%) , AMPH Amphastar $19.17 / -0.21 (-1.08%) , INSP Inspire Medical $217.98 / -0.26 (-0.12%) , NWS News Corp $24.73 / -0.19 (-0.76%) , ACRX AcelRx $2.17 / -0.04 (-1.81%) , ASLE AerSale $11.15 / +1.155 (+11.56%) , HQY HealthEquity $80.26 / +1.09 (+1.38%) , CLSK CleanSpark $29.40 / -1.5 (-4.85%) , IMAX Imax $23.45 / -0.02 (-0.09%) , NKLA Nikola $17.07 / +0.07 (+0.41%) , RUBI Rubicon Project $0.00 / + (+0.00%) , MAXR Maxar Technologies $47.79 / +1.07 (+2.29%) , PAYA Paya Holdings $13.28 / +0.03 (+0.23%) Check out this evening's… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options PAYA NWS NKLA MAXR INSP IMAX HQY CLSK ASLE AMPH ACRX PAYA Paya Holdings $13.28 / +0.03 (+0.23%) 03/02/21 Point72 Asset Management reports 5.5% passive stake in Paya Holdings 02/25/21 Paya's FIrst Billings Services, Agent 511 announce strategic partnership 02/09/21 Paya Holdings' payment solution certified by Acumatica 11/02/20 Paya Holdings appoints Matt Humphries as head of investor relations NWS News Corp $24.73 / -0.19 (-0.76%) 03/15/21 Facebook, News Corp reach multi-year agreement in Australia 03/15/21 News Corp jumps 3.5% to $25.58 after disclosing Rupert Murdoch insider buy 03/15/21 News Corp executive chairman buys 500K shares of common stock 02/17/21 News Corp, Google agree to three-year news partnership NKLA Nikola $17.07 / +0.07 (+0.41%) 02/25/21 Nikola sees delivering first Nikola Tre BEVs to customers during Q4 02/25/21 Nikola CEO says 'necessary changes' made in Q4 to 'refocus and realign' company 02/23/21 Nikola provides update on North American hydrogen fuel-cell vehicle program 01/14/21 Worthington sells it remaining 7.05M shares of Nikola MAXR Maxar Technologies $47.79 / +1.07 (+2.29%) 03/10/21 Maxar Technologies completes Spider robotic arm Critical Design Review for NASA 01/21/21 Maxar Technologies falls -7.3% 01/14/21 Maxar Technologies rises 27.9% 01/14/21 Maxar Technologies rises 14.3% INSP Inspire Medical $217.98 / -0.26 (-0.12%) 03/15/21 Inspire Medical gets FDA approval of two-incision implant procedure 01/19/21 Inspire appoints Bryan Phillips as chief compliance officer, general counsel 11/03/20 Inspire Medical rises 23.2% 11/03/20 Inspire Medical rises 19.1% IMAX Imax $23.45 / -0.02 (-0.09%) 03/11/21 Imax and visual effect company Maximus in JV, for in-home A.I. video enhancement 03/10/21 Imax, Broadway sign new four-theatre deal in Shanghai 03/09/21 Imax signs 4-theater deal in Shanghai with exhibitor Broadway 03/05/21 Imax rises 9.4% HQY HealthEquity $80.26 / +1.09 (+1.38%) 03/08/21 HealthEquity acquires Luum, terms not disclosed 01/11/21 HealthEquity expects 5.7M-5.8M HSA members by Jan. 31 CLSK CleanSpark $29.40 / -1.5 (-4.85%) 03/09/21 CleanSpark acquires 1,150 new miners capable of producing 100 PH/s 02/09/21 CleanSpark provides acquisition update on Bitcoin mining operations 02/03/21 CleanSpark announces multi-unit switchgear order for commercial microgrids 01/21/21 CleanSpark says investigating short seller Culper Research, calls claims 'false' ASLE AerSale $11.15 / +1.155 (+11.56%) 01/05/21 AerSale announces additional Boeing 757 conversions at Arizona facility AMPH Amphastar $19.17 / -0.21 (-1.08%) 12/29/20 Amphastar jumps 26% to $23.98 after FDA approval for generic glucagon kit 12/29/20 Amphastar announces approval for Glucagon for Injection Kit, 1mg 12/28/20 Amphastar granted FDA approval of generic glucagon for injection 10/06/20 Amphastar receives FDA approval for Atropine Sulfate injection ACRX AcelRx $2.17 / -0.04 (-1.81%) 03/15/21 AcelRx sees FY21 CapEx $4M-$5M 02/17/21 AcelRx signs agreement for study of Dsuvia in plastic surgery 02/16/21 FDA posts warning letter sent to AcelRx over Dsuvia marketing materials 01/19/21 AcelRx announces investigator-initiated study to evaluate DSUVIA ZDGE AMPH INSP NWS ACRX ASLE HQY CLSK IMAX NKLA RUBI MAXR PAYA ZDGE Zedge $11.48 / +1.2 (+11.67%) 02/11/21 Fly Intel: Top five analyst initiations 02/11/21 Maxim Zedge initiated with a Buy at Maxim AMPH Amphastar $19.17 / -0.21 (-1.08%) 01/08/21 Wells Fargo Amphastar downgraded to Equal Weight from Overweight at Wells Fargo 10/05/20 Northland Amphastar upgraded to Outperform from Market Perform at Northland 07/09/20 Northland Amphastar downgraded to Market Perform from Outperform at Northland 05/01/20 Fly Intel: Top five analyst initiations INSP Inspire Medical $217.98 / -0.26 (-0.12%) 02/24/21 Lake Street Inspire Medical price target raised to $250 from $215 at Lake Street 02/24/21 SVB Leerink Inspire Medical price target raised to $275 from $225 at SVB Leerink 02/24/21 Piper Sandler Inspire Medical price target raised to $252 from $210 at Piper Sandler 01/07/21 Lake Street Inspire Medical price target raised to $215 from $150 at Lake Street NWS News Corp $24.73 / -0.19 (-0.76%) ACRX AcelRx $2.17 / -0.04 (-1.81%) 02/17/21 H.C. Wainwright AcelRx warning letter is a 'nothingburger,' says H.C. Wainwright 07/24/20 H.C. Wainwright AcelRx deal with Zimmer Biomet a 'win-win,' says H.C. Wainwright 07/20/20 Fly Intel: Top five analyst downgrades 07/20/20 Credit Suisse AcelRx downgraded to Underperform on 'mounting challenges' at Credit Suisse ASLE AerSale $11.15 / +1.155 (+11.56%) 01/07/21 Cowen AerSale initiated with a Market Perform at Cowen HQY HealthEquity $80.26 / +1.09 (+1.38%) 02/10/21 Raymond James HealthEquity price target raised to $100 from $75 at Raymond James 02/09/21 Barrington HealthEquity price target raised to $90 from $75 at Barrington 02/09/21 Truist HealthEquity price target raised to $92 from $80 at Truist 02/09/21 RBC Capital HealthEquity price target raised to $87 from $74 at RBC Capital CLSK CleanSpark $29.40 / -1.5 (-4.85%) 03/10/21 BTIG CleanSpark initiated with a Buy at BTIG 03/10/21 BTIG CleanSpark initiated with a Buy at BTIG 02/16/21 H.C. Wainwright CleanSpark price target raised to $50 from $24 at H.C. Wainwright 12/11/20 H.C. Wainwright CleanSpark price target raised to $24 from $18 at H.C. Wainwright IMAX Imax $23.45 / -0.02 (-0.09%) 03/09/21 Barrington Imax price target raised to $27 from $25 at Barrington 03/05/21 Macquarie Imax price target raised to $25 after Q4 earnings beat at Macquarie 03/05/21 Benchmark Imax price target raised to $24 from $22 at Benchmark 03/01/21 Wedbush Imax price target raised to $22 from $14 at Wedbush NKLA Nikola $17.07 / +0.07 (+0.41%) 03/05/21 Fly Intel: Top five analyst downgrades 03/05/21 JPMorgan JPMorgan lowers Bloom Energy target but now prefers over Nikola 03/05/21 JPMorgan Nikola downgraded to Neutral from Overweight at JPMorgan 02/01/21 Fly Intel: Top five analyst upgrades RUBI Rubicon Project $0.00 / + (+0.00%) 06/26/20 B. Riley Rubicon Project meetings suggest Q2 outlook conservative, says B. Riley FBR 04/02/20 Craig-Hallum Rubicon Project price target lowered to $9 from $14 at Craig-Hallum MAXR Maxar Technologies $47.79 / +1.07 (+2.29%) 02/25/21 Canaccord Maxar Technologies price target raised to $55 from $50 at Canaccord 02/19/21 Canaccord Maxar Technologies price target raised to $50 from $40 at Canaccord 01/21/21 Fly Intel: Top five analyst downgrades 01/21/21 JPMorgan JPMorgan downgrades Maxar, says take profits after 85% rally PAYA Paya Holdings $13.28 / +0.03 (+0.23%) 03/08/21 BTIG Paya Holdings Q4 shows bull thesis intact, says BTIG 02/26/21 Raymond James Paya Holdings initiated with an Outperform at Raymond James 02/23/21 DA Davidson Paya Holdings initiated with a Buy at DA Davidson 02/23/21 DA Davidson Paya Holdings initiated with a Buy at DA Davidson ZDGE PAYA NWS NKLA MAXR INSP IMAX HQY CLSK ASLE AMPH ACRX ZDGE Zedge $11.48 / +1.2 (+11.67%) 03/15/21 Zedge reports Q2 EPS 17c, one estimate 4c PAYA Paya Holdings $13.28 / +0.03 (+0.23%) 03/08/21 Paya Holdings sees FY21 revenue $234M-$242M, consensus $237.97M 03/08/21 Paya Holdings reports Q4 revenue $54M consensus $53.3M 11/09/20 Paya Holdings reports Q3 revenue $51.8M, consensus $53.35M NWS News Corp $24.73 / -0.19 (-0.76%) 02/04/21 News Corp. reports Q2 adjutsed EPS 34c, consensus 10c 11/05/20 News Corp. reports Q1 adjusted EPS 8c, consensus 0c NKLA Nikola $17.07 / +0.07 (+0.41%) 02/25/21 Nikola reports Q4 adjusted EPS (17c), consensus (23c) 02/25/21 Notable companies reporting after market close 11/09/20 Nikola reports Q3 adjusted EPS (16c), consensus (19c) 11/09/20 Notable companies reporting after market close MAXR Maxar Technologies $47.79 / +1.07 (+2.29%) 02/24/21 Maxar Technologies reports Q4 EPS (65c) vs 70c last year 11/05/20 Maxar Technologies maintains FY20 adj. EBITDA view of $415M-$445M INSP Inspire Medical $217.98 / -0.26 (-0.12%) 11/02/20 Inspire Medical raises FY20 revenue view to $110M-$112M from $88M-$92M 11/02/20 Inspire Medical reports Q3 EPS (39c), consensus (72c) IMAX Imax $23.45 / -0.02 (-0.09%) 03/04/21 Imax reports Q4 adjusted EPS (21c), consensus (20c) 10/29/20 Imax reports Q3 EPS (75c), consensus (30c) HQY HealthEquity $80.26 / +1.09 (+1.38%) 03/15/21 HealthEquity sees FY22 EPS $1.37-$1.42, consensus $1.70 03/15/21 HealthEquity reports Q4 EPS 42c, consensus 39c 03/15/21 Notable companies reporting after market close 02/09/21 HealthEquity raises FY21 EPS view to $1.67-$1.71 from $1.55-$1.61 CLSK CleanSpark $29.40 / -1.5 (-4.85%) 10/21/20 CleanSpark backs FY21 revenue view $20M, consensus $22.87M 10/21/20 CleanSpark sees FY20 revenue over $10.0M, one estimate $10.22M ASLE AerSale $11.15 / +1.155 (+11.56%) 03/15/21 AerSale reports Q4 adjusted EBITDA $3.3M vs. $23.8M last year AMPH Amphastar $19.17 / -0.21 (-1.08%) 03/15/21 Amphastar reports Q4 EPS 16c, consensus 14c 11/06/20 Amphastar reports Q3 adjusted EPS 15c, consensus 14c ACRX AcelRx $2.17 / -0.04 (-1.81%) 03/15/21 AcelRx reports Q4 EPS (10c), consensus (10c) 01/14/21 AcelRx reports preliminary FY20 revenue approximately $5.4M, consensus $7.25M 11/05/20 AcelRx reports Q3 EPS (10c), consensus (8c) 18 Mar 16 Mar 18 Mar 17 Feb 20 Jan 07 Oct 09 Jul 14 Apr NWS NKLA IMAX CLSK NWS News Corp $24.73 / -0.19 (-0.76%) 12/09/20 Advertising tech firm PubMatic spikes almost 50% in IPO, CNBC says 11/24/20 Bertelsmann in lead to buy Simon & Schuster from ViacomCBS, FT reports NKLA Nikola $17.07 / +0.07 (+0.41%) 02/26/21 Nikola's review finds several of Milton's claims 'inaccurate,' FT reports 02/16/21 Churchill Capital soars after Reuters says deal with Lucid Motors is close 02/16/21 Churchill Capital Corp IV near deal to bring Lucid Motors public, Reuters says 02/12/21 Nikola, APS electricity deal approved by state regulators, AZ Big Media says IMAX Imax $23.45 / -0.02 (-0.09%) 03/12/21 L.A. County officials say movie theaters can reopen Monday, Deadline says 03/10/21 Movie theaters in L.A. could reopen as early as Saturday, CNBC reports 02/22/21 Movie theaters might get OK to reopen in New York City, Deadline says 10/18/20 NY state moves to reopen movie theaters, ski resorts, Bloomberg reports CLSK CleanSpark $29.40 / -1.5 (-4.85%) 01/14/21 Culper Research issues short report on CleanSpark, calls stock 'uninvestible' 10/08/20 CleanSpark named as short idea by White Diamond Research NWS NKLA MAXR INSP IMAX HQY CLSK AMPH NWS News Corp $24.73 / -0.19 (-0.76%) 02/04/21 Fly Intel: After-Hours Movers NKLA Nikola $17.07 / +0.07 (+0.41%) 03/05/21 Boeing upgrade, Nikola downgrade among today's top calls on Wall Street 02/27/21 Charged: Tesla temporarily halts Model 3 line at CA plant 02/23/21 Fly Intel: Wall Street's top stories at midday 02/23/21 SPACs slide after Lucid Motors confirms anticipated come-public deal MAXR Maxar Technologies $47.79 / +1.07 (+2.29%) 02/24/21 Fly Intel: After-Hours Movers INSP Inspire Medical $217.98 / -0.26 (-0.12%) 11/03/20 Fly Intel: Wall Street's top stories for Tuesday 11/03/20 Fly Intel: Wall Street's top stories at midday 11/02/20 Fly Intel: After-Hours Movers IMAX Imax $23.45 / -0.02 (-0.09%) 03/04/21 Fly Intel: After-Hours Movers 12/28/20 AMC, Cinemark rise as WW84 scores highest box office opening of pandemic 12/03/20 Fly Intel: Wall Street's top stories for Thursday 11/24/20 Fly Intel: Wall Street's top stories for Tuesday HQY HealthEquity $80.26 / +1.09 (+1.38%) 02/16/21 Fly Intel: After-Hours Movers CLSK CleanSpark $29.40 / -1.5 (-4.85%) 03/12/21 The Intersection: Crypto and Wall Street This Week 01/22/21 The Intersection: Crypto and Wall Street This Week 01/14/21 Fly Intel: Wall Street's top stories for Thursday 01/08/21 The Intersection: Crypto and Wall Street This Week AMPH Amphastar $19.17 / -0.21 (-1.08%) 02/16/21 Fly Insider: Power REIT, Amphastar among week's notable insider trades 03/16/21 2021 Industrials Virtual Conference 03/19/21 Electric Truck Day 03/25/21 Benzinga Biotech Small Cap Virtual Conference 03/15/21 HealthEquity - HQY 03/15/21 Zedge - ZDGE 03/15/21 AcelRx - ACRX 03/15/21 Amphastar - AMPH 03/22/21 Paya Holdings - PAYA 03/23/21 Paya Holdings 04/21/21 HealthEquity ZDGE PAYA NWS NKLA MAXR IMAX CLSK ACRX ZDGE Zedge $11.48 / +1.2 (+11.67%) 11/23/20 Seven new option listings and six option delistings on November 23rd PAYA Paya Holdings $13.28 / +0.03 (+0.23%) 03/09/21 Largest borrow rate increases among liquid names NWS News Corp $24.73 / -0.19 (-0.76%) 11/06/20 Early notable gainers among liquid option names on November 6th NKLA Nikola $17.07 / +0.07 (+0.41%) 03/11/21 Nikola call volume above normal and directionally bullish 02/25/21 Nikola options imply 19.4% move in share price post-earnings 02/03/21 Nikola call volume above normal and directionally bullish 01/27/21 Nikola call volume above normal and directionally bullish MAXR Maxar Technologies $47.79 / +1.07 (+2.29%) 09/28/20 Largest borrow rate increases among liquid names IMAX Imax $23.45 / -0.02 (-0.09%) 01/05/21 Largest borrow rate increases among liquid names 11/10/20 IMAX call buyer realizes 525% same-day gains 10/23/20 Largest borrow rate increases among liquid names 09/23/20 Unusual call flow in option market yesterday CLSK CleanSpark $29.40 / -1.5 (-4.85%) 02/18/21 CleanSpark call volume above normal and directionally bullish 01/29/21 CleanSpark call volume above normal and directionally bullish 01/11/21 Largest borrow rate increases among liquid names 12/10/20 CleanSpark call volume above normal and directionally bullish ACRX AcelRx $2.17 / -0.04 (-1.81%) 10/21/20 Largest borrow rate increases among liquid names 10/20/20 Largest borrow rate increases among liquid names
Hot Stocks	Inspire Medical gets FDA approval of two-incision implant procedure » 16:14 03/15/21 03/15 16:14 03/15/21 16:14 INSP Inspire Medical $217.93 / -0.31 (-0.14%) Inspire Medical Systems… Inspire Medical Systems announced receipt of U.S. Food and Drug Administration approval for an improved surgical implant procedure that eliminates one incision with a revised placement of the pressure sensing lead. This newly approved procedure will reduce the average procedure time for Inspire therapy by approximately 20% ."Delivering consistent positive patient outcomes remains Inspire's number one priority, and the receipt of FDA approval for this two-incision procedure represents further evidence of our commitment to the continuous improvement of Inspire therapy," said Tim Herbert, President and Chief Executive Officer of Inspire Medical Systems. "The new procedure places the sensor in the intercostal muscles directly behind the neurostimulator pocket, thereby eliminating the need for a third incision lower on the chest and the additional requirement to tunnel the sensing lead under the skin to the neurostimulator. A number of ENT surgeons highly experienced with the current Inspire implant procedure initiated the development of this new surgical technique. With this approval, we now intend to leverage our broad network of leading ENT's to further improve the Inspire procedure and enhance therapy outcomes." ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly INSP Inspire Medical $217.93 / -0.31 (-0.14%) 01/19/21 Inspire appoints Bryan Phillips as chief compliance officer, general counsel 11/03/20 Inspire Medical rises 23.2% 11/03/20 Inspire Medical rises 19.1% 10/22/20 Inspire Medical appoints Shelley Broader to board of directors INSP Inspire Medical $217.93 / -0.31 (-0.14%) 02/24/21 Lake Street Inspire Medical price target raised to $250 from $215 at Lake Street 02/24/21 SVB Leerink Inspire Medical price target raised to $275 from $225 at SVB Leerink 02/24/21 Piper Sandler Inspire Medical price target raised to $252 from $210 at Piper Sandler 01/07/21 Lake Street Inspire Medical price target raised to $215 from $150 at Lake Street INSP Inspire Medical $217.93 / -0.31 (-0.14%) 11/02/20 Inspire Medical raises FY20 revenue view to $110M-$112M from $88M-$92M 11/02/20 Inspire Medical reports Q3 EPS (39c), consensus (72c) 14 Apr INSP Inspire Medical $217.93 / -0.31 (-0.14%) 11/03/20 Fly Intel: Wall Street's top stories for Tuesday 11/03/20 Fly Intel: Wall Street's top stories at midday 11/02/20 Fly Intel: After-Hours Movers

Conference/Events	Inspire Medical participates in a conference call with JPMorgan » 09:53 03/05/21 03/05 09:53 03/05/21 09:53 INSP Inspire Medical $211.00 / -4.73 (-2.19%) Medical Supplies &… Medical Supplies & Devices Analyst Marcus holds a conference call with CEO Herbert on March 5 at 11 am hosted by JPMorgan. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly INSP Inspire Medical $211.00 / -4.73 (-2.19%) 01/19/21 Inspire appoints Bryan Phillips as chief compliance officer, general counsel 11/03/20 Inspire Medical rises 23.2% 11/03/20 Inspire Medical rises 19.1% 10/22/20 Inspire Medical appoints Shelley Broader to board of directors INSP Inspire Medical $211.00 / -4.73 (-2.19%) 02/24/21 Lake Street Inspire Medical price target raised to $250 from $215 at Lake Street 02/24/21 SVB Leerink Inspire Medical price target raised to $275 from $225 at SVB Leerink 02/24/21 Piper Sandler Inspire Medical price target raised to $252 from $210 at Piper Sandler 01/07/21 Lake Street Inspire Medical price target raised to $215 from $150 at Lake Street INSP Inspire Medical $211.00 / -4.73 (-2.19%) 11/02/20 Inspire Medical raises FY20 revenue view to $110M-$112M from $88M-$92M 11/02/20 Inspire Medical reports Q3 EPS (39c), consensus (72c) 14 Apr INSP Inspire Medical $211.00 / -4.73 (-2.19%) 11/03/20 Fly Intel: Wall Street's top stories for Tuesday 11/03/20 Fly Intel: Wall Street's top stories at midday 11/02/20 Fly Intel: After-Hours Movers
Recommendations	Inspire Medical price target raised to $250 from $215 at Lake Street » 09:02 02/24/21 02/24 09:02 02/24/21 09:02 INSP Inspire Medical $220.00 / -3.32 (-1.49%) Lake Street analyst Frank… Lake Street analyst Frank Takkinen raised the firm's price target on Inspire Medical to $250 from $215 and keeps a Buy rating on the shares after the company reported accelerating revenue growth in Q4 and gave what he calls "impressive" guidance. He sees the company "building a durable competitive moat to further protect their impressive lead to competition," Takkinen tells investors in a post-earnings research note. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly INSP Inspire Medical $220.00 / -3.32 (-1.49%) 01/19/21 Inspire appoints Bryan Phillips as chief compliance officer, general counsel 11/03/20 Inspire Medical rises 23.2% 11/03/20 Inspire Medical rises 19.1% 10/22/20 Inspire Medical appoints Shelley Broader to board of directors INSP Inspire Medical $220.00 / -3.32 (-1.49%) 02/24/21 SVB Leerink Inspire Medical price target raised to $275 from $225 at SVB Leerink 02/24/21 Piper Sandler Inspire Medical price target raised to $252 from $210 at Piper Sandler 01/07/21 Lake Street Inspire Medical price target raised to $215 from $150 at Lake Street 01/04/21 BofA Inspire Medical downgraded to Neutral from Buy at BofA INSP Inspire Medical $220.00 / -3.32 (-1.49%) 11/02/20 Inspire Medical raises FY20 revenue view to $110M-$112M from $88M-$92M 11/02/20 Inspire Medical reports Q3 EPS (39c), consensus (72c) 14 Apr INSP Inspire Medical $220.00 / -3.32 (-1.49%) 11/03/20 Fly Intel: Wall Street's top stories for Tuesday 11/03/20 Fly Intel: Wall Street's top stories at midday 11/02/20 Fly Intel: After-Hours Movers
Recommendations	Inspire Medical price target raised to $275 from $225 at SVB Leerink » 07:54 02/24/21 02/24 07:54 02/24/21 07:54 INSP Inspire Medical $220.00 / -3.32 (-1.49%) SVB Leerink analyst… SVB Leerink analyst Richard Newitter raised the firm's price target on Inspire Medical to $275 from $225 and keeps an Outperform rating on the shares following the company's Q4 revenue beat and above consensus 2021 revenue outlook. The analyst continues to believe Inspire Medical is at a reimbursement "tipping point" that should lead to accelerated adoption and continued upward bias to consensus out-year forecasts as the company is in a strong position to penetrate a large/still underpenetrated TAM. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly INSP Inspire Medical $220.00 / -3.32 (-1.49%) 01/19/21 Inspire appoints Bryan Phillips as chief compliance officer, general counsel 11/03/20 Inspire Medical rises 23.2% 11/03/20 Inspire Medical rises 19.1% 10/22/20 Inspire Medical appoints Shelley Broader to board of directors INSP Inspire Medical $220.00 / -3.32 (-1.49%) 02/24/21 Piper Sandler Inspire Medical price target raised to $252 from $210 at Piper Sandler 01/07/21 Lake Street Inspire Medical price target raised to $215 from $150 at Lake Street 01/04/21 BofA Inspire Medical downgraded to Neutral from Buy at BofA 12/15/20 Goldman Sachs Inspire Medical downgraded to Neutral from Buy at Goldman Sachs INSP Inspire Medical $220.00 / -3.32 (-1.49%) 11/02/20 Inspire Medical raises FY20 revenue view to $110M-$112M from $88M-$92M 11/02/20 Inspire Medical reports Q3 EPS (39c), consensus (72c) 14 Apr INSP Inspire Medical $220.00 / -3.32 (-1.49%) 11/03/20 Fly Intel: Wall Street's top stories for Tuesday 11/03/20 Fly Intel: Wall Street's top stories at midday 11/02/20 Fly Intel: After-Hours Movers
Recommendations	Inspire Medical price target raised to $252 from $210 at Piper Sandler » 04:50 02/24/21 02/24 04:50 02/24/21 04:50 INSP Inspire Medical $220.00 / -3.32 (-1.49%) Piper Sandler analyst… Piper Sandler analyst Adam Maeder raised the firm's price target on Inspire Medical to $252 from $210 and reiterates an Overweight rating on the shares following the company's Q4 results. While the quarter was aided to a modest degree by catch-up procedures, the underlying strength was "evident and impressive," Maeder tells investors in a research note. Inspire is bringing "substantial commercial" momentum into 2021 despite COVID-19, says the analyst. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly INSP Inspire Medical $220.00 / -3.32 (-1.49%) 01/19/21 Inspire appoints Bryan Phillips as chief compliance officer, general counsel 11/03/20 Inspire Medical rises 23.2% 11/03/20 Inspire Medical rises 19.1% 10/22/20 Inspire Medical appoints Shelley Broader to board of directors INSP Inspire Medical $220.00 / -3.32 (-1.49%) 01/07/21 Lake Street Inspire Medical price target raised to $215 from $150 at Lake Street 01/04/21 BofA Inspire Medical downgraded to Neutral from Buy at BofA 12/15/20 Goldman Sachs Inspire Medical downgraded to Neutral from Buy at Goldman Sachs 12/03/20 Piper Sandler Inspire Medical price target raised to $210 from $147 at Piper Sandler INSP Inspire Medical $220.00 / -3.32 (-1.49%) 11/02/20 Inspire Medical raises FY20 revenue view to $110M-$112M from $88M-$92M 11/02/20 Inspire Medical reports Q3 EPS (39c), consensus (72c) 14 Apr INSP Inspire Medical $220.00 / -3.32 (-1.49%) 11/03/20 Fly Intel: Wall Street's top stories for Tuesday 11/03/20 Fly Intel: Wall Street's top stories at midday 11/02/20 Fly Intel: After-Hours Movers
Hot Stocks	Inspire appoints Bryan Phillips as chief compliance officer, general counsel » 16:08 01/19/21 01/19 16:08 01/19/21 16:08 INSP Inspire Medical $224.07 / +14.13 (+6.73%) , CERE Cerevel Therapeutics $14.51 / +0.095 (+0.66%) Inspire Medical (INSP)… Inspire Medical (INSP) announced the appointment of Bryan Phillips as senior VP, general counsel, chief compliance officer and corporate secretary. Phillips is a legal executive with broad corporate experience in the healthcare industry.Most recently, Phillips served as chief legal officer at Cerevel Therapeutics (CERE). ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly INSP CERE INSP Inspire Medical $224.07 / +14.13 (+6.73%) 11/03/20 Inspire Medical rises 23.2% 11/03/20 Inspire Medical rises 19.1% 10/22/20 Inspire Medical appoints Shelley Broader to board of directors 09/01/20 Inspire Medical announces Humana coverage for Inspire Therapy CERE Cerevel Therapeutics $14.51 / +0.095 (+0.66%) 01/19/21 Frequency Therapeutics appoints Quentin McCubbin as chief manufacturing officer 12/08/20 Cerevel Therapeutics appoints Ruth McKernan to board of directors 10/30/20 Cerevel Therapeutics doses first patients in Phase 3 trials of tavapadon 10/28/20 Cerevel Therapeutics debuts as publicly-traded neuroscience company INSP CERE INSP Inspire Medical $224.07 / +14.13 (+6.73%) 01/07/21 Lake Street Inspire Medical price target raised to $215 from $150 at Lake Street 01/04/21 BofA Inspire Medical downgraded to Neutral from Buy at BofA 12/15/20 Goldman Sachs Inspire Medical downgraded to Neutral from Buy at Goldman Sachs 12/03/20 Piper Sandler Inspire Medical price target raised to $210 from $147 at Piper Sandler CERE Cerevel Therapeutics $14.51 / +0.095 (+0.66%) 12/10/20 Goldman Sachs Cerevel Therapeutics initiated with a Buy at Goldman Sachs 11/23/20 Jefferies Cerevel Therapeutics initiated with a Buy at Jefferies 11/09/20 Fly Intel: Top five analyst initiations 11/09/20 Stifel Cerevel Therapeutics initiated with a Buy at Stifel INSP INSP Inspire Medical $224.07 / +14.13 (+6.73%) 11/02/20 Inspire Medical raises FY20 revenue view to $110M-$112M from $88M-$92M 11/02/20 Inspire Medical reports Q3 EPS (39c), consensus (72c) 08/04/20 Inspire Medical reports Q2 EPS (88c), consensus ($1.10) 14 Apr INSP CERE INSP Inspire Medical $224.07 / +14.13 (+6.73%) 11/03/20 Fly Intel: Wall Street's top stories for Tuesday 11/03/20 Fly Intel: Wall Street's top stories at midday 11/02/20 Fly Intel: After-Hours Movers CERE Cerevel Therapeutics $14.51 / +0.095 (+0.66%) 11/16/20 Fly Insider: Cerevel Therapeutics, Paylocity among weeks notable insider trades

On The Fly

News and insights, exclusive to thefly.com

20:25	Notable companies reporting before tomorrow's open»
14:11	Notable companies reporting before tomorrow's open»
14:09	Notable companies reporting after market close»
09:53	Fly Intel: Top five analyst initiations»
09:53	Fly Intel: Top five analyst downgrades»

View all On The Fly Stories »

Upcoming
Events (10)

RAIN	Rain Therapeutics - RAIN
BKYI	BIO-key - BKYI
RP	RealPage - RP
	After COVID-19: Building an Inclusive Economy for California
JKS ...	China Solar Demand
IMCC ...	KCSA Cannabis Investor Virtual Conference
	73rd Annual Virtual Meeting of AAN
	Spring Mining Virtual Conference
ARHH ...	Planet MicroCap Virtual Showcase
MRNS	Marinus Pharmaceuticals

View all of today’s events »

Today’s
Syndicate (3)

CHWY	Block Trade
IFBD	IPO
TRKA	IPO

View this week’s syndicate »

Get Full Fly Access

Breaking market intelligence sent straight to you: Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.

Up-to-date information on important industry events: Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.

News focused on the companies in your portfolio: Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.

14 Day Free Trial